Global Blood Therapeutics, Inc. Current Liabilities
Global Blood Therapeutics, Inc. had Current Liabilities of $93.09 million as of 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2022-08-08
- 2022-06-30: Liabilities, Current $93.09M.
- 2022-03-31: Liabilities, Current $79.31M.
- 2021-12-31: Liabilities, Current $88.00M.
- 2021-09-30: Liabilities, Current $74.06M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2022-06-30 | $93.09M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $79.31M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $88.00M 10-Q · filed 2022-08-08 | |
| 2021-09-30 | $74.06M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $72.67M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $58.97M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $79.03M 10-K · filed 2022-02-23 | |
| 2020-09-30 | $77.95M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $69.40M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $62.25M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $71.45M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $41.19M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $39.71M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $32.09M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $33.77M 10-K · filed 2020-02-26 | |
| 2018-09-30 | $26.93M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $21.29M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $23.96M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $26.26M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $16.36M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $17.15M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $14.75M 10-Q · filed 2017-05-01 | |
| 2016-12-31 | $15.52M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $13.16M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $13.16M 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $11.49M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $9.63M 10-K · filed 2017-03-13 | $10.72M 10-K · filed 2016-03-29 |
| 2015-09-30 | $6.57M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $5.23M 10-Q · filed 2015-09-24 | |
| 2014-12-31 | $2.54M 10-K · filed 2016-03-29 |